Q32 Bio Inc. (QTTB) Other Non-Current Liabilities (2023 - 2025)

Q32 Bio has reported Other Non-Current Liabilities for 3 years, with the latest figure at $55.0 million in Q3 2025.

• On a quarterly basis, Other Non-Current Liabilities changed 0.0% year-over-year to $55.0 million in Q3 2025; TTM through Sep 2025 was $55.0 million, a 0.0% change from a year earlier, with the FY2024 full-year figure at $55.0 million, changed 0.0% from the prior year.
• Other Non-Current Liabilities was $55.0 million for Q3 2025 at Q32 Bio, roughly flat from $55.0 million in the prior quarter.
• The five-year high for Other Non-Current Liabilities was $55.1 million in Q1 2024, with the low at $55.0 million in Q4 2023.
• Average Other Non-Current Liabilities over 3 years is $55.0 million, with a median of $55.0 million recorded in 2023.
• The sharpest annual moves came in 2024 and 2025: Other Non-Current Liabilities changed 0.0% in 2024, then retreated 0.21% in 2025.
• Over 3 years, Other Non-Current Liabilities stood at $55.0 million in 2023, then changed by 0.0% to $55.0 million in 2024, then changed by 0.0% to $55.0 million in 2025.
• The last three Other Non-Current Liabilities figures came in at $55.0 million (Q3 2025), $55.0 million (Q2 2025), and $55.0 million (Q1 2025), per Business Quant data.